Literature DB >> 25005120

Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Marcus A Bearse1, Glen Y Ozawa.   

Abstract

In this review article, we first present a brief overview of the vascular and neural components of diabetic retinopathy. Next, the multifocal electroretinogram (mfERG) technique, which can map neuroretinal function noninvasively, is described. Findings in diabetic retinal disease using the mfERG are reviewed. We then describe the progress that has been made to predict the onset and progression of diabetic retinopathy and edema in specific retinal locations, using quantitative models based on the mfERG. Finally, we consider the implications for the future of these predictive models.

Entities:  

Mesh:

Year:  2014        PMID: 25005120     DOI: 10.1007/s11892-014-0526-9

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  63 in total

1.  The optic nerve head component of the human ERG.

Authors:  E E Sutter; M A Bearse
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

2.  Effects of APB, PDA, and TTX on ERG responses recorded using both multifocal and conventional methods in monkey. Effects of APB, PDA, and TTX on monkey ERG responses.

Authors:  William A Hare; Hau Ton
Journal:  Doc Ophthalmol       Date:  2002-09       Impact factor: 2.379

3.  Diabetic retinopathy.

Authors:  J R WOLTER
Journal:  Am J Ophthalmol       Date:  1961-05       Impact factor: 5.258

4.  Diabetic retinopathy viewed as a neurosensory disorder.

Authors:  G H Bresnick
Journal:  Arch Ophthalmol       Date:  1986-07

5.  Association between local neuroretinal function and control of adolescent type 1 diabetes.

Authors:  Michal Laron; Marcus A Bearse; Kevin Bronson-Castain; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-09       Impact factor: 4.799

6.  The nature and extent of retinal dysfunction associated with diabetic macular edema.

Authors:  V C Greenstein; K Holopigian; D C Hood; W Seiple; R E Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

Review 7.  Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.

Authors:  José Cunha-Vaz; Rui Bernardes
Journal:  Prog Retin Eye Res       Date:  2004-12-16       Impact factor: 21.198

8.  Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy.

Authors:  Marcus A Bearse; Ying Han; Marilyn E Schneck; Shirin Barez; Carl Jacobsen; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

9.  Reproducibility of the mfERG between instruments.

Authors:  Wendy W Harrison; Marcus A Bearse; Jason S Ng; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Doc Ophthalmol       Date:  2009-03-26       Impact factor: 2.379

Review 10.  Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.

Authors:  Timothy S Kern
Journal:  Exp Diabetes Res       Date:  2007
View more
  14 in total

1.  Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus.

Authors:  P Carpineto; L Toto; R Aloia; V Ciciarelli; E Borrelli; E Vitacolonna; M Di Nicola; L Di Antonio; R Mastropasqua
Journal:  Eye (Lond)       Date:  2016-02-12       Impact factor: 3.775

2.  Long-term full-field and multifocal electroretinographic changes after treatment with ranibizumab in patients with diabetic macular edema.

Authors:  Kenan Yigit; Ümit Übeyt Inan; Sibel Inan; Mustafa Dogan; Guliz Fatma Yavas; Ersan Cetinkaya
Journal:  Int Ophthalmol       Date:  2021-01-23       Impact factor: 2.031

Review 3.  Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy.

Authors:  Ghislain Opdenakker; Ahmed Abu El-Asrar
Journal:  Cell Mol Life Sci       Date:  2019-06-10       Impact factor: 9.261

4.  Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy.

Authors:  Jason C Park; Felix Y Chau; Jennifer I Lim; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2019-04-23       Impact factor: 2.379

Review 5.  Clinical electroretinography in diabetic retinopathy: a review.

Authors:  J Jason McAnany; Oksana S Persidina; Jason C Park
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

6.  Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.

Authors:  Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

Review 7.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

8.  Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema.

Authors:  Rodolfo Mastropasqua; Lisa Toto; Enrico Borrelli; Luca Di Antonio; Chiara De Nicola; Alessandra Mastrocola; Marta Di Nicola; Paolo Carpineto
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 9.  Neuroinflammatory responses in diabetic retinopathy.

Authors:  Ying Yu; Hui Chen; Shao Bo Su
Journal:  J Neuroinflammation       Date:  2015-08-07       Impact factor: 8.322

10.  Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.

Authors:  Michael D Abramoff; Patrice E Fort; Ian C Han; K Thiran Jayasundera; Elliott H Sohn; Thomas W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.